Page results
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. These…
-
The Adult Acute speech and language therapist (SLTs) work across a range of acute hospital specialities.
-
Pioneering neurologist who worked at NHNN is commemorated with an English Heritage London blue plaque at his Wimpole Street home where he had his private practice.
-
All medications given to you while you are an inpatient are provided free of charge. At follow-up appointments, you may be given a prescription by your doctor or nurse. This must be collected from the hospital pharmacy; you cannot take it to your local chemist. There is a standard prescription charge per item which you can pay for by cash or card.
-
The psychology team will be running this 8-week online parent mindfulness group for parents of children and young people under a medical team at UCLH.
-
Here is an invitation to the Medtronic diabetes patient education web events.
File results
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0936 - Policy and Procedure management at Trust
-
FOI/2023/0938 - Trust pain management education provided to staff
-
FOI/2023/0941 - Paediatric audiology services 2023
-
FOI/2023/0943 - Cancellation of planned surgical procedures
-
FOI/2023/0946 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer
-
FOI/2023/0957 - Maternity services intervention statistics; still birth, elective C-section, emergency C-section
-
FOI/2023/0961 - Robotic Process Automation staff details